世界のリポソームイリノテカン市場:成長動向・競争分析2020-2026

【英語タイトル】Global Liposomal Irinotecan Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが出版した調査資料(QYR20AP01323)・商品コード:QYR20AP01323
・発行会社(調査会社):QYResearch
・発行日:2020年3月25日(※2024年版があります。お問い合わせください)
・ページ数:118
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当リサーチレポートでは、リポソームイリノテカンの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、リポソームイリノテカンのグローバル市場動向、メーカー別競争状況、種類別市場規模(43mg、50mg)、用途別市場規模(病院、薬局)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・リポソームイリノテカンの種類別市場2015-2026:43mg、50mg
・リポソームイリノテカンの用途別市場2015-2026:病院、薬局
・リポソームイリノテカンの北米市場分析
・リポソームイリノテカンのアジア市場分析
・リポソームイリノテカンの中南米市場分析
・リポソームイリノテカンの中東・アフリカ市場分析
・関連企業情報:Ipsen
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Irinotecan, sold under the brand name Camptosar among others, is a medication used to treat colon cancer, and small cell lung cancer. In 2019, the global Liposomal Irinotecan market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% during the forecast period. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Liposomal Irinotecan.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Liposomal Irinotecan market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Liposomal Irinotecan market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Liposomal Irinotecan market. Readers of the report can become informed about current and future trends of the global Liposomal Irinotecan market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Liposomal Irinotecan markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Liposomal Irinotecan market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Liposomal Irinotecan market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Liposomal Irinotecan market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Liposomal Irinotecan market is segmented into
43mg
50mg

Market Segment by Application, the Liposomal Irinotecan market is segmented into
Hospital
Drugs Store

This report includes the following manufacturers; we can also add the other companies as you want.
Ipsen

The study objectives are:
To analyze and research the global Liposomal Irinotecan status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Liposomal Irinotecan manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Liposomal Irinotecan are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Liposomal Irinotecan Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Liposomal Irinotecan Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 43mg
1.3.3 50mg
1.4 Market Segment by Application
1.4.1 Global Liposomal Irinotecan Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Hospital
1.4.3 Drugs Store
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Liposomal Irinotecan Revenue (2015-2026)
2.1.1 Global Liposomal Irinotecan Revenue (2015-2026)
2.1.2 Global Liposomal Irinotecan Sales (2015-2026)
2.2 Liposomal Irinotecan Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Liposomal Irinotecan Sales by Regions (2015-2020)
2.2.2 Global Liposomal Irinotecan Revenue by Regions (2015-2020)
2.3 Global Top Liposomal Irinotecan Regions (Countries) Ranking by Market Size
2.4 Liposomal Irinotecan Industry Trends
2.4.1 Liposomal Irinotecan Market Top Trends
2.4.2 Market Drivers
2.4.3 Liposomal Irinotecan Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Liposomal Irinotecan Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Liposomal Irinotecan Manufacturers by Sales (2015-2020)
3.1.1 Global Liposomal Irinotecan Sales by Manufacturers (2015-2020)
3.1.2 Global Liposomal Irinotecan Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Liposomal Irinotecan Sales in 2019
3.2 Global Top Manufacturers Liposomal Irinotecan by Revenue
3.2.1 Global Liposomal Irinotecan Revenue by Manufacturers (2015-2020)
3.2.2 Global Liposomal Irinotecan Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Liposomal Irinotecan Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposomal Irinotecan as of 2019)
3.4 Global Liposomal Irinotecan Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Liposomal Irinotecan Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Liposomal Irinotecan Market
3.7 Key Manufacturers Liposomal Irinotecan Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Liposomal Irinotecan Historic Market Review by Type (2015-2020)
4.1.2 Global Liposomal Irinotecan Sales Market Share by Type (2015-2020)
4.1.3 Global Liposomal Irinotecan Revenue Market Share by Type (2015-2020)
4.1.4 Liposomal Irinotecan Price by Type (2015-2020)
4.1 Global Liposomal Irinotecan Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Liposomal Irinotecan Sales Forecast by Type (2021-2026)
4.2.3 Global Liposomal Irinotecan Revenue Forecast by Type (2021-2026)
4.2.4 Liposomal Irinotecan Price Forecast by Type (2021-2026)

5 Global Liposomal Irinotecan Market Size by Application
5.1 Global Liposomal Irinotecan Historic Market Review by Application (2015-2020)
5.1.2 Global Liposomal Irinotecan Sales Market Share by Application (2015-2020)
5.1.3 Global Liposomal Irinotecan Revenue Market Share by Application (2015-2020)
5.1.4 Liposomal Irinotecan Price by Application (2015-2020)
5.2 Global Liposomal Irinotecan Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Liposomal Irinotecan Sales Forecast by Application (2021-2026)
5.2.3 Global Liposomal Irinotecan Revenue Forecast by Application (2021-2026)
5.2.4 Liposomal Irinotecan Price Forecast by Application (2021-2026)

6 North America
6.1 North America Liposomal Irinotecan Breakdown Data by Company
6.2 North America Liposomal Irinotecan Breakdown Data by Type
6.3 North America Liposomal Irinotecan Breakdown Data by Application
6.4 North America Liposomal Irinotecan Breakdown Data by Countries
6.4.1 North America Liposomal Irinotecan Sales by Countries
6.4.2 North America Liposomal Irinotecan Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Liposomal Irinotecan Breakdown Data by Company
7.2 Europe Liposomal Irinotecan Breakdown Data by Type
7.3 Europe Liposomal Irinotecan Breakdown Data by Application
7.4 Europe Liposomal Irinotecan Breakdown Data by Countries
7.4.1 Europe Liposomal Irinotecan Sales by Countries
7.4.2 Europe Liposomal Irinotecan Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Liposomal Irinotecan Breakdown Data by Company
8.2 Asia Pacific Liposomal Irinotecan Breakdown Data by Type
8.3 Asia Pacific Liposomal Irinotecan Breakdown Data by Application
8.4 Asia Pacific Liposomal Irinotecan Breakdown Data by Regions
8.4.1 Asia Pacific Liposomal Irinotecan Sales by Regions
8.4.2 Asia Pacific Liposomal Irinotecan Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Liposomal Irinotecan Breakdown Data by Company
9.2 Latin America Liposomal Irinotecan Breakdown Data by Type
9.3 Latin America Liposomal Irinotecan Breakdown Data by Application
9.4 Latin America Liposomal Irinotecan Breakdown Data by Countries
9.4.1 Latin America Liposomal Irinotecan Sales by Countries
9.4.2 Latin America Liposomal Irinotecan Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Liposomal Irinotecan Breakdown Data by Type
10.2 Middle East and Africa Liposomal Irinotecan Breakdown Data by Application
10.3 Middle East and Africa Liposomal Irinotecan Breakdown Data by Countries
10.3.1 Middle East and Africa Liposomal Irinotecan Sales by Countries
10.3.2 Middle East and Africa Liposomal Irinotecan Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Ipsen
11.1.1 Ipsen Corporation Information
11.1.2 Ipsen Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Ipsen Liposomal Irinotecan Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Ipsen Liposomal Irinotecan Products and Services
11.1.5 Ipsen SWOT Analysis
11.1.6 Ipsen Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Liposomal Irinotecan Sales Channels
12.2.2 Liposomal Irinotecan Distributors
12.3 Liposomal Irinotecan Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Liposomal Irinotecan Sales Forecast (2021-2026)
13.1.1 Global Liposomal Irinotecan Sales Forecast by Regions (2021-2026)
13.1.2 Global Liposomal Irinotecan Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Liposomal Irinotecan Sales Forecast (2021-2026)
13.2.2 North America Liposomal Irinotecan Revenue Forecast (2021-2026)
13.2.3 North America Liposomal Irinotecan Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Liposomal Irinotecan Sales Forecast (2021-2026)
13.3.2 Europe Liposomal Irinotecan Revenue Forecast (2021-2026)
13.3.3 Europe Liposomal Irinotecan Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Liposomal Irinotecan Sales Forecast (2021-2026)
13.4.2 Asia Pacific Liposomal Irinotecan Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Liposomal Irinotecan Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Liposomal Irinotecan Sales Forecast (2021-2026)
13.5.2 Latin America Liposomal Irinotecan Revenue Forecast (2021-2026)
13.5.3 Latin America Liposomal Irinotecan Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Liposomal Irinotecan Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Liposomal Irinotecan Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Liposomal Irinotecan Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Liposomal Irinotecan Key Market Segments
Table 2. Ranking of Global Top Liposomal Irinotecan Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Liposomal Irinotecan Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
Table 4. Major Manufacturers of 43mg
Table 5. Major Manufacturers of 50mg
Table 6. Global Liposomal Irinotecan Market Share by Application 2019-2025 (K Units)
Table 7. Global Liposomal Irinotecan Market Size by Regions 2015-2020 (K Units) & (Million US$)
Table 8. Global Liposomal Irinotecan Sales by Regions 2015-2020 (K Units)
Table 9. Global Liposomal Irinotecan Sales Market Share by Regions 2015-2020
Table 10. Global Liposomal Irinotecan Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Liposomal Irinotecan Revenue Market Share by Regions 2015-2020
Table 12. Top Liposomal Irinotecan Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Liposomal Irinotecan Key Drivers: Impact Analysis (2021-2026)
Table 15. Liposomal Irinotecan Key Challenges
Table 16. Main Points Interviewed from Key Liposomal Irinotecan Players: Views for Future
Table 17. Global Liposomal Irinotecan Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Liposomal Irinotecan Sales Share by Manufacturers (2015-2020)
Table 19. Liposomal Irinotecan Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Liposomal Irinotecan Revenue Share by Manufacturers (2015-2020)
Table 21. Global Liposomal Irinotecan Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposomal Irinotecan as of 2019)
Table 23. Key Manufacturers Liposomal Irinotecan Average Selling Price (ASP) (2015-2020) (US$/Unit)
Table 24. Key Manufacturers Liposomal Irinotecan Plants/Factories Distribution
Table 25. Key Manufacturers Liposomal Irinotecan Area Served
Table 26. Date of Key Manufacturers Enter into Liposomal Irinotecan Market
Table 27. Key Manufacturers Liposomal Irinotecan Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global 43mg Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 30. Global 50mg Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 31. Global Liposomal Irinotecan Sales (K Units) by Type (2015-2020)
Table 32. Global Liposomal Irinotecan Sales Share by Type (2015-2020)
Table 33. Global Liposomal Irinotecan Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Liposomal Irinotecan Price (K Units) by Type (2015-2020)
Table 35. Global Liposomal Irinotecan Sales (K Units) by Type (2021-2026)
Table 36. Global Liposomal Irinotecan Sales Share by Type (2021-2026)
Table 37. Global Liposomal Irinotecan Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Liposomal Irinotecan Revenue Share by Type (2021-2026)
Table 39. Global Liposomal Irinotecan Price (K Units) by Type (2021-2026)
Table 40. Global Liposomal Irinotecan Sales (K Units) by Application (2015-2020)
Table 41. Global Liposomal Irinotecan Sales Share by Application (2015-2020)
Table 42. Global Liposomal Irinotecan Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Liposomal Irinotecan Price by Application 2015-2020 (US$/Unit)
Table 44. Global Liposomal Irinotecan Sales by Application (2015-2020) (K Units)
Table 45. Global Liposomal Irinotecan Sales Share by Application (2015-2020)
Table 46. Global Liposomal Irinotecan Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Liposomal Irinotecan Revenue Share by Application (2021-2026)
Table 48. Global Liposomal Irinotecan Price (K Units) by Application (2021-2026)
Table 49. North America Liposomal Irinotecan Sales by Company (2015-2020) (K Units)
Table 50. North America Liposomal Irinotecan Sales Market Share by Company (2015-2020)
Table 51. North America Liposomal Irinotecan Sales by Type (2015-2020) (K Units)
Table 52. North America Liposomal Irinotecan Sales Market Share by Type (2015-2020)
Table 53. North America Liposomal Irinotecan Sales by Application (2015-2020) (K Units)
Table 54. North America Liposomal Irinotecan Sales Market Share by Application (2015-2020)
Table 55. North America Liposomal Irinotecan Sales by Countries (2015-2020) (K Units)
Table 56. North America Liposomal Irinotecan Sales Market Share by Countries (2015-2020)
Table 57. North America Liposomal Irinotecan Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Liposomal Irinotecan Revenue Market Share by Countries (2015-2020)
Table 59. Europe Liposomal Irinotecan Sales by Company (2015-2020) (K Units)
Table 60. Europe Liposomal Irinotecan Sales Market Share by Company (2015-2020)
Table 61. Europe Liposomal Irinotecan Sales by Type (2015-2020) (K Units)
Table 62. Europe Liposomal Irinotecan Sales Market Share by Type (2015-2020)
Table 63. Europe Liposomal Irinotecan Sales by Application (2015-2020) (K Units)
Table 64. Europe Liposomal Irinotecan Sales Market Share by Application (2015-2020)
Table 65. Europe Liposomal Irinotecan Sales by Countries (2015-2020) (K Units)
Table 66. Europe Liposomal Irinotecan Sales Market Share by Countries (2015-2020)
Table 67. Europe Liposomal Irinotecan Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Liposomal Irinotecan Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Liposomal Irinotecan Sales by Regions (2015-2020) (K Units)
Table 70. Asia Pacific Liposomal Irinotecan Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Liposomal Irinotecan Sales by Type (2015-2020) (K Units)
Table 72. Asia Pacific Liposomal Irinotecan Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Liposomal Irinotecan Sales by Application (2015-2020) (K Units)
Table 74. Asia Pacific Liposomal Irinotecan Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Liposomal Irinotecan Sales by Countries (2015-2020) (K Units)
Table 76. Asia Pacific Liposomal Irinotecan Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Liposomal Irinotecan Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Liposomal Irinotecan Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Liposomal Irinotecan Sales by Company (2015-2020) (K Units)
Table 80. Latin America Liposomal Irinotecan Sales Market Share by Company (2015-2020)
Table 81. Latin America Liposomal Irinotecan Sales by Type (2015-2020) (K Units)
Table 82. Latin America Liposomal Irinotecan Sales Market Share by Type (2015-2020)
Table 83. Latin America Liposomal Irinotecan Sales by Application (2015-2020) (K Units)
Table 84. Latin America Liposomal Irinotecan Sales Market Share by Application (2015-2020)
Table 85. Latin America Liposomal Irinotecan Sales by Countries (2015-2020) (K Units)
Table 86. Latin America Liposomal Irinotecan Sales Market Share by Countries (2015-2020)
Table 87. Latin America Liposomal Irinotecan Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Liposomal Irinotecan Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Liposomal Irinotecan Sales by Type (2015-2020) (K Units)
Table 90. Middle East and Africa Liposomal Irinotecan Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Liposomal Irinotecan Sales by Application (2015-2020) (K Units)
Table 92. Middle East and Africa Liposomal Irinotecan Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Liposomal Irinotecan Sales by Countries (2015-2020) (K Units)
Table 94. Middle East and Africa Liposomal Irinotecan Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Liposomal Irinotecan Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Liposomal Irinotecan Revenue Market Share by Countries (2015-2020)
Table 97. Ipsen Company Details
Table 98. Ipsen Description and Business Overview
Table 99. Ipsen Liposomal Irinotecan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 100. Ipsen Liposomal Irinotecan Sales Growth Rate (2015-2020)
Table 101. Ipsen Liposomal Irinotecan Sales Market Share in Global Market
Table 102. Ipsen Recent Development
Table 103. Liposomal Irinotecan Distributors List
Table 104. Liposomal Irinotecan Customers List
Table 105. Global Liposomal Irinotecan Sales Forecast 2021-2026 (K Units) & (Million US$)
Table 106. Global Liposomal Irinotecan Sales Forecast by Type 2021-2026 (K Units)
Table 107. Global Liposomal Irinotecan Sales Forecast by Application 2021-2026 (K Units)
Table 108. Global Liposomal Irinotecan Sales Forecast by Regions 2021-2026 (K Units)
Table 109. Global Liposomal Irinotecan Revenue Forecast by Regions 2021-2026 (Million US$)
Table 110. North America Liposomal Irinotecan Sales Forecast by Countries 2021-2026 (K Units)
Table 111. North America Liposomal Irinotecan Revenue Forecast by Countries 2021-2026
Table 112. Europe Liposomal Irinotecan Sales Forecast by Countries 2021-2026 (K Units)
Table 113. Europe Liposomal Irinotecan Revenue Market Share Forecast by Countries 2021-2026
Table 114. Asia Pacific Liposomal Irinotecan Sales Forecast by Regions 2021-2026 (K Units)
Table 115. Asia Pacific Liposomal Irinotecan Revenue Forecast by Regions 2021-2026 (Million US$)
Table 116. Latin America Liposomal Irinotecan Sales Forecast by Countries 2021-2026 (K Units)
Table 117. Latin America Liposomal Irinotecan Revenue Forecast by Countries 2021-2026 (Million US$)
Table 118. Middle East and Africa Liposomal Irinotecan Sales Forecast by Regions 2021-2026 (K Units)
Table 119. Middle East and Africa Liposomal Irinotecan Revenue Forecast by Regions 2021-2026 (Million US$)
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Liposomal Irinotecan Product Picture
Figure 2. Global Liposomal Irinotecan Sales Market Shar by Type 2015-2026
Figure 3. 43mg Figures
Figure 4. 50mg Figures
Figure 5. Global Liposomal Irinotecan Sales Market Share by Application in 2019 & 2026
Figure 6. Hospital Use Case
Figure 7. Drugs Store Use Case
Figure 8. Liposomal Irinotecan Report Years Considered
Figure 9. Global Liposomal Irinotecan Market Size 2015-2026 (Million US$)
Figure 10. Global Liposomal Irinotecan Sales 2015-2020 (K Units)
Figure 11. Global Liposomal Irinotecan Market Size Market Share by Regions 2015-2020
Figure 12. Global Liposomal Irinotecan Sales Market Share by Regions in 2019
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Liposomal Irinotecan Sales Share by Manufacturers in 2019
Figure 15. The 5 and 10 Largest Manufacturers in the World: Market Share by Liposomal Irinotecan Sales in 2019
Figure 16. Liposomal Irinotecan Value Share by Manufacturers in 2019
Figure 17. Liposomal Irinotecan Revenue Share by Manufacturers In 2019
Figure 18. Liposomal Irinotecan Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Liposomal Irinotecan Revenue Share by Type (2015-2020)
Figure 20. Global Liposomal Irinotecan Revenue Growth Rate by Type in 2015 & 2019
Figure 21. Global Liposomal Irinotecan Market Share by Price Range (2015-2020)
Figure 22. Global Liposomal Irinotecan Revenue Share by Application (2015-2020)
Figure 23. Global Liposomal Irinotecan Revenue Growth Rate by Application in 2015 & 2019
Figure 24. North America Liposomal Irinotecan Revenue Growth Rate 2015-2020 (Million US$)
Figure 25. U.S. Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 26. Canada Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 27. Europe Liposomal Irinotecan Revenue Growth Rate 2015-2020 (Million US$)
Figure 28. Germany Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 29. France Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 30. U.K. Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 31. Italy Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 32. Russia Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 33. Asia Pacific Liposomal Irinotecan Revenue Growth Rate 2015-2020 (Million US$)
Figure 34. China Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 35. Japan Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 36. South Korea Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 37. India Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 38. Australia Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 39. Taiwan Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 40. Indonesia Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 41. Thailand Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 42. Malaysia Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 43. Philippines Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 44. Vietnam Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 45. Latin America Liposomal Irinotecan Revenue Growth Rate 2015-2020 (Million US$)
Figure 46. Mexico Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 47. Brazil Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 48. Argentina Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 49. Middle East and Africa Liposomal Irinotecan Revenue Growth Rate 2015-2020 (Million US$)
Figure 50. Turkey Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 51. Saudi Arabia Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 52. U.A.E Liposomal Irinotecan Sales Growth Rate (2015-2020) (K Units)
Figure 53. Ipsen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Liposomal Irinotecan Value Chain
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. North America Liposomal Irinotecan Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 58. North America Liposomal Irinotecan Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 59. Europe Liposomal Irinotecan Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 60. Europe Liposomal Irinotecan Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 61. Asia Pacific Liposomal Irinotecan Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 62. Asia Pacific Liposomal Irinotecan Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 63. Latin America Liposomal Irinotecan Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 64. Latin America Liposomal Irinotecan Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 65. Middle East and Africa Liposomal Irinotecan Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 66. Middle East and Africa Liposomal Irinotecan Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed


【掲載企業】

Ipsen

★調査レポート[世界のリポソームイリノテカン市場:成長動向・競争分析2020-2026] (コード:QYR20AP01323)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のリポソームイリノテカン市場:成長動向・競争分析2020-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆